Stanley Alkemade
Fondatore presso Worldwide BioMedEx, Inc.
Profilo
Stanley Alkemade is the founder of Worldwide BioMedEx, Inc. He is currently the President of BiomedEx Pty Ltd.
His former positions include Chief Executive Officer at Viron Therapeutics, Inc. and Director at NovaVive, Inc. He was also an Independent Non-Executive Director at Telesta Therapeutics, Inc. from 2013 to 2013.
Dr. Alkemade holds a doctorate degree from the University of Melbourne.
Posizioni attive di Stanley Alkemade
| Società | Posizione | Inizio |
|---|---|---|
| BiomedEx Pty Ltd. | Presidente | - |
| Worldwide BioMedEx, Inc. | Fondatore | - |
Precedenti posizioni note di Stanley Alkemade
| Società | Posizione | Fine |
|---|---|---|
| TELESTA THERAPEUTICS INC | Direttore/Membro del Consiglio | 05/11/2013 |
NovaVive, Inc.
 NovaVive, Inc. BiotechnologyHealth Technology NovaVive, Inc. provides biotechnology services. The company was founded in 2014 and is headquartered in Belleville, Canada. | Direttore/Membro del Consiglio | - |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Presidente | - |
Formazione di Stanley Alkemade
| University of Melbourne | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Health Technology |
| BiomedEx Pty Ltd. | |
| Worldwide BioMedEx, Inc. | |
NovaVive, Inc.
NovaVive, Inc. BiotechnologyHealth Technology NovaVive, Inc. provides biotechnology services. The company was founded in 2014 and is headquartered in Belleville, Canada. | Health Technology |
- Borsa valori
- Insiders
- Stanley Alkemade
